--Greif Increases Quarterly Dividend to $0.54 a Share, Payable on Oct. 1 to Shareholders on Sept. 16-March 2024-www.financetom.com

Business

--Greif Increases Quarterly Dividend to $0.54 a Share, Payable on Oct. 1 to Shareholders on Sept. 16

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

--Greif Increases Quarterly Dividend to $0.54 a Share, Payable on Oct. 1 to Shareholders on Sept. 16

Aug 29, 2024 4:36 AM

12:40 PM EDT, 08/27/2024 (MT Newswires) --

Price: 63.35, Change: -0.27, Percent Change: -0.42

Previous page： Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing Next page： Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Adaptive Biotechnologies Insider Sold Shares Worth $1,315,180, According to a Recent SEC Filing

Nov 13, 2025

03:54 AM EST, 11/13/2025 (MT Newswires) -- Chad M Robins, Director, Chief Executive Officer and Chairman, on November 10, 2025, sold 89,265 shares in Adaptive Biotechnologies ( ADPT ) for $1,315,180. Following the Form 4 filing with the SEC, Robins has control over a total of 2,869,975 common shares of the company, with 2,869,975 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1478320/000178064925000002/xslF345X05/primary_doc.xml...

Carvana Insider Sold Shares Worth $3,250,300, According to a Recent SEC Filing

Nov 13, 2025

03:55 AM EST, 11/13/2025 (MT Newswires) -- Ryan S. Keeton, Chief Brand Officer, on November 10, 2025, sold 10,000 shares in Carvana ( CVNA ) for $3,250,300. Following the Form 4 filing with the SEC, Keeton has control over a total of 104,958 Class A common shares of the company, with 104,958 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1690820/000170054225000011/xslF345X05/wk-form4_1762991500.xml ...

Halozyme Therapeutics Insider Sold Shares Worth $4,167,930, According to a Recent SEC Filing

Nov 13, 2025

03:56 AM EST, 11/13/2025 (MT Newswires) -- Helen Torley, Director, President and Chief Executive Officer, on November 10, 2025, sold 60,000 shares in Halozyme Therapeutics ( HALO ) for $4,167,930. Following the Form 4 filing with the SEC, Torley has control over a total of 733,719 common shares of the company, with 733,719 shares held directly. SEC Filing: https://www.sec.gov/Archives/edgar/data/1159036/000115903625000054/xslF345X05/wk-form4_1762991674.xml ...

SBC Medical Group Announces Commencement of Tender Offer for Shares of Waqoo, Inc.

Nov 13, 2025

TOKYO--(BUSINESS WIRE)-- SBC Medical Group Holdings Incorporated ( SBC ) , a global provider of comprehensive consulting and management services to the medical corporations and their clinics, today announced that on November 13, 2025, SBC Medical Group Co., Ltd. (the “Tender Offeror”) has resolved to acquire shares of common stock of Waqoo, Inc. through a tender offer (the “Tender Offer”)...

About

Terms and Conditions Privacy policy Cookie Settings Contact Us

Services

financetom Market Personal Finance Business Economy Cryptocurrency MAP